We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.45
Bid: 35.20
Ask: 35.60
Change: 0.05 (0.14%)
Spread: 0.40 (1.136%)
Open: 35.45
High: 35.65
Low: 35.20
Prev. Close: 35.40
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: BP and Prudential help snap FTSE losing streak

Tue, 06th Feb 2024 17:04

(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major BP the star performer.

The FTSE 100 index ended up 68.15 points, 0.9%, at 7,681.01. London's large-cap index was on a four-day losing streak ahead of Tuesday's session.

The FTSE 250 ended 152.79 points higher, 0.8%, at 19,171.34, and the AIM All-Share rose 3.80 points, 0.5%, at 754.17.

The Cboe UK 100 shot up 1.1% at 769.35, the Cboe UK 250 added 1.0% at 16,613.67, but the Cboe Small Companies faded 0.3% to 14,638.59.

In mainland Europe, the CAC 40 in Paris rose 0.7%, while the DAX 40 in Frankfurt climbed 0.7%.

In New York, the Dow Jones Industrial Average was up 0.2% at the time of the closing bell in Europe. The S&P 500 was only marginally higher, while the Nasdaq Composite was a touch lower.

The European open received some impetus after bullish trade in Asia, on policy support measures to boost beleaguered shares. Stocks exposed to China were among the better performers in London, with Asia-focused insurer Prudential up 3.8%.

There was also some better data which bolstered sentiment in Europe. The European Central Bank said that median expectations for inflation over the next 12 months decreased as it published a consumer expectation survey from December.

Median expectations for inflation over the next 12 months eased to 3.2% in December from 3.5% in November. The ECB said that this was the third consecutive month of decline.

Meanwhile, new manufacturing orders in Germany unexpectedly rose in December, according to preliminary data, marking an improvement from the previous month for Europe's largest economy.

According to Destatis, factory orders rose by 8.9% on-month in December, after being stagnant from October to November. FXStreet were expecting factory orders to be stagnant.

In the UK, the downturn in the construction sector eased slightly at the start of the year, according to a survey.

The S&P Global UK construction purchasing managers' index rose to 48.8 points in January from 46.8 points in December. This marks the highest reading since August 2023 and is higher than FXStreet market consensus of 47.3 points.

That said, the index remained below the crucial 50.0 no-change threshold for the fifth month running.

The pound was quoted at USD1.2590 late Tuesday in London, higher compared to USD1.2527 at the equities close on Monday. The euro stood at USD1.0749, up slightly against USD1.0728. Against the yen, the dollar was trading at JPY148.09, lower compared to JPY148.80.

In London, BP shares shot up 5.3%.

XTB analyst Kathleen Brooks commented: "Although 2023 full year profits were shy of estimates, the strong Q4 performance suggests that the company gathered steam at the end of last year, which is a good backdrop for 2024's performance. There was good news on gas trading and its profitable convenience line, which saw gross margins soar, the company also jumped on the AI bandwagon."

BP said it completed its USD1.5 billion share buyback on Friday, and now intends to initiate a new USD1.75 billion buyback, prior to reporting its first quarter results which are due on May 7. It intends to buy back USD3.5 billion in shares for the first half of 2024.

BP added that it plans to conduct share buybacks worth at least USD14 billion through 2025, as part of its commitment to return at least 80% of surplus cash flow to shareholders.

In 2023, revenue dropped by 14% to USD213.03 billion from USD248.89 billion in 2022. However, pretax profit jumped by 54% to USD23.75 billion from USD15.41 billion.

Renishaw surged 16%.

The Gloucestershire, England-based provider of manufacturing technologies, analytical instruments and medical devices said pretax profit fell 27% to GBP56.5 million in the six months that ended December 31 from GBP77.8 million a year before.

Revenue declined 4.9% to GBP330.5 million from GBP347.7 million a year earlier.

Despite the weaker results, Renishaw left its dividend unchanged at 16.8 pence per share.

Looking ahead, Chief Executive Officer William Lee said: "We expect an improvement in our trading performance in the second half of the financial year as market conditions improve, and as we continue to pursue a range of growth opportunities. To support our through-cycle growth strategy, we are continuing to focus on productivity and to make targeted investments in our people, our production facilities, and our new product pipeline."

Elsewhere in London, Futura Medical shares jumped 40% as it hailed its first "meaningful" from product sales.

The Guildford, Surrey-based pharmaceutical company expects to report GBP3.1 million revenue for 2023. No revenue was recognised in 2022.

Chief Executive Officer James Barder said: "I am incredibly proud to report that we have delivered on the three key objectives that we set out in 2023: achieving regulatory approval in the US; progressing commercial discussions by securing a standout distribution partner in Haleon for the largest consumer healthcare market in the world and reporting our first meaningful revenues. The delivery of this progress, alongside the fact that we have an award-winning product, has given us a robust and broad platform to build upon in the year ahead."

Aston Martin Lagonda shares fell 3.9%.

News of seven-time Formula One world champion Lewis Hamilton's switch to Ferrari from Mercedes dominated automotive space chatter last week. Aston Martin Lagonda, is sizing up a personnel change of its own, according to Bloomberg.

A Bloomberg report said Executive Chair Lawrence Stroll has contacted current and former heads of other luxury auto manufacturers to gauge interest in the role, citing people familiar with the matter.

It would mark the fourth change in CEO at the luxury car manufacturer in as many years.

Stroll tapped Felisa, formerly the boss of Ferrari between 2008 and 2016, to be CEO in May 2022. He replaced former Mercedes-AMG boss Tobias Moers, who spent less than two years in the job. His predecessor, Andy Palmer, left months after Stroll rescued Aston Martin in early 2020.

Brent oil was quoted at USD78.57 a barrel at the time of the London equities close on Tuesday, up from USD77.11 late Monday. Gold traded at USD2,036.43 an ounce against USD2,019.86.

Wednesday's economic calendar has a Halifax UK house price index reading and German industrial production data at 0700 GMT.

In the local corporate calendar, housebuilder Barratt Developments and emerging markets-focused asset manager Ashmore release half-year results. Packaging firm Smurfit Kappa reports annual results.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
10 Apr 2024 10:49

Futura Medical hails results as erectile dysfunction drug drives sales

(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction treatment climbed.

Read more
3 Apr 2024 12:58

UK earnings, trading statements calendar - next 7 days

Thursday 4 April 
LungLife AI IncFull Year Results
Friday 5 April 
no events scheduled 
Monday 8 April 
Bango PLCFull Year Results
Ferrexpo PLCTrading Statement
Globaltrans Investment PLCFull Year Results
Tuesday 9 April 
Alliance Pharma PLCFull Year Results
CMC Markets PLCTrading Statement
hVIVO PLCFull Year Results
Imperial Brands PLCTrading Statement
JTC PLCFull Year Results
S&U PLCFull Year Results
Ultimate Products PLCHalf Year Results
Wednesday 10 April 
Churchill China PLCFull Year Results
Futura Medical PLCFull Year Results
M&C Saatchi PLCFull Year Results
Marshalls PLCFull Year Results
Tesco PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
14 Feb 2024 09:24

IN BRIEF: Futura Medical's Eroxon to soon be available on prescription

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England and Wales for the treatment of erectile dysfunction. Eroxon is a gel-based treatment designed to help the user obtain an erection, and serves as an alternative for people who are unwilling or unable to use medications like Viagra. Eroxon has also been available without a prescription in UK pharmacies since March last year.

Read more
6 Feb 2024 12:24

Futura Medical shares surge after "transformational year"

(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.

Read more
6 Feb 2024 10:08

Futura has 'transformational year' in 2023

(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration".

Read more
15 Jan 2024 14:59

Futura Medical extends agreement with Cooper Consumer Health

(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.

Read more
15 Jan 2024 08:35

Futura Medical extends licensing deal for erectile dysfunction gel

(Alliance News) - Futura Medical PLC on Monday said that it has extended its exclusive licensing agreement with Cooper Consumer Health Group, a European self-care organisation, to January 2029.

Read more
7 Nov 2023 17:47

TRADING: Zambeef sees profit above market views; Luceco trades in line

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
25 Oct 2023 12:21

Futura Medical gets Mexico marketing authorisation for Eroxon gel

(Alliance News) - Futura Medical PLC on Wednesday said the Mexican Secretariat of Health has granted over the counter sale marketing authorisation for its erectile dysfunction topical gel formulation Eroxon.

Read more
19 Oct 2023 14:17

IN BRIEF: Futura Medical launches erectile dysfunction gel in UAE

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says that it has launched Exoron in the United Arab Emirates. Exoron, or MED3000, is a topical gel used to treat erectile dysfunction. It uses Futura's proprietary technology, DermaSys. The product is now available for purchase online through the BinSina Pharmacy in the UAE, the first market in the Middle East to stock the product.

Read more
2 Oct 2023 14:22

Futura Medical wis European patent for erectile dysfunction gel

(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.

Read more
2 Oct 2023 12:13

IN BRIEF: Futura Medical granted European patent for ED treatment

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Receives European patent for erectile dysfunction treatment, MED3000, until 2040. Continues to pursue patent applications to provide wider patent protection. Chief Executive Officer James Barder says: "The allowance of this patent application further cements the intellectual property of MED3000, as we support our distributors' roll out of our fast acting topically applied gel for the treatment of erectile dysfunction available without a doctor's prescription across the world."

Read more
18 Sep 2023 11:28

TRADING UPDATES: Elixirr record half-year revenue; Bango profit down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Sep 2023 15:44

UK earnings, trading statements calendar - next 7 days

Tuesday 12 September 
Associated British Foods PLCTrading Statement
Cornerstone FS PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Digital 9 Infrastructure PLCHalf Year Results
Dowlais Group PLCHalf Year Results
Eleco PLCHalf Year Results
Equals Group PLCHalf Year Results
Feedback PLCFull Year Results
Fevertree Drinks PLCHalf Year Results
Gym Group PLCHalf Year Results
Harworth Group PLCHalf Year Results
hVIVO PLCHalf Year Results
IQE PLCHalf Year Results
Itaconix PLCHalf Year Results
JTC PLCHalf Year Results
Keywords Studios PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocean Harvest Technology Group PLCHalf Year Results
Property Franchise Group PLCHalf Year Results
Regional REIT LtdHalf Year Results
Smart Metering Systems PLCHalf Year Results
Wednesday 13 September 
abrdn Smaller Companies Income Trust PLCHalf Year Results
Argentex Group PLCHalf Year Results
Brave Bison Group PLCHalf Year Results
Burford Capital LtdHalf Year Results
CAB Payments Holdings PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Frontier Developments PLCFull Year Results
Made Tech Group PLCFull Year Results
On The Beach Group PLCTrading Statement
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Ricardo PLCFull Year Results
Star Energy Group PLCHalf Year Results
Tullow Oil PLCHalf Year Results
Thursday 14 September 
Arecor Therapeutics PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Capricorn Energy PLCHalf Year Results
Checkit PLCHalf Year Results
Churchill China PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Glenveagh Properties PLCHalf Year Results
IG Group Holdings PLCTrading Statement
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
M&C Saatchi PLCHalf Year Results
MJ Gleeson PLCFull Year Results
Oakley Capital Investments LtdHalf Year Results
Renishaw PLCFull Year Results
Spire Healthcare Group PLCHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Uniphar PLCHalf Year Results
Friday 15 September 
Petra Diamonds LtdFull Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Monday 18 September 
Artisanal Spirits Co PLCHalf Year Results
City of London Investment Group PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Futura Medical PLCHalf Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
S4 Capital PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.